Progentec and GSK Collab on Virtual Lupus Diagnostics
Progentec launched a study with GSK aimed at identifying people at risk of developing lupus and guiding their virtual diagnostic journey.
Read MorePosted by Andy Lundin | Mar 22, 2023 | Allergy & Autoimmune |
Progentec launched a study with GSK aimed at identifying people at risk of developing lupus and guiding their virtual diagnostic journey.
Read MorePosted by Andy Lundin | Mar 20, 2023 | Pancreatic |
A research team identified biomarkers that could help distinguish whether cysts on the pancreas will develop into cancer or remain benign.
Read MorePosted by Chris Wolski | Mar 20, 2023 | Leukemia, Molecular Diagnostic Analyzers |
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read MorePosted by Andy Lundin | Mar 17, 2023 | Disease States |
Multiple sclerosis experts are advocating for genetic testing to identify MS patients at risk of developing side effects from medications.
Read MorePosted by Andy Lundin | Mar 17, 2023 | Company News |
Enzo Biochem, has entered into an agreement for Labcorp to acquire the assets of Enzo’s clinical laboratory division, Enzo Clinical Labs.
Read More